| CAS ID: | 55268-74-1 |
| Molecular Formula: | C19H24N2O2 |
| Molecular Weight: | 312.4 g/mol |
| Monoisotopic Mass: | 312.1838 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PRAZIQUANTEL | EMBAY 8440 | Droncit | CESOL | BILTRICIDE | Cestocur | CYSTICIDE | CISTICID | EMBAY-8440 |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 28408356 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 28483578 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSC proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting IFN-γ signaling and TGF-β signaling | ||
Trial Record 1
| ClinicalTrial ID | NCT01260012 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Unknown |
| First Received | December 15, 2010 | Last Verified | December 15, 2010 |
| Sponsor | Addis Ababa University | ||
Trial Record 2
| ClinicalTrial ID | NCT01260012 | Disease | Periportal fibrosis |
| Phase | Not Applicable | Status | Unknown |
| First Received | December 15, 2010 | Last Verified | December 15, 2010 |
| Sponsor | Addis Ababa University | ||